Overexpression of PD-L1 has been implicated as a mechanism of immune-evasion in lung cancer as well as other solid tumors, and has been reported to be associated with the presence of sensitizing EGFR mutations in selected lung cancer cell lines [20–23] and resected non-small cell lung cancer [23–25]. Here, EGFR is linked to lung carcinoma.